avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maz
|
ENSMUSG00000030678.8 | Maz |
Zfp281
|
ENSMUSG00000041483.15 | Zfp281 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Maz | mm39_v1_chr7_-_126625617_126625653 | 0.75 | 1.7e-07 | Click! |
Zfp281 | mm39_v1_chr1_+_136552639_136552688 | 0.22 | 2.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 30.2 | GO:0034118 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
8.6 | 25.9 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
7.9 | 23.6 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
7.2 | 28.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
6.8 | 20.4 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
5.8 | 17.4 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
5.5 | 16.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
5.4 | 21.7 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
5.4 | 65.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
5.1 | 30.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
5.0 | 15.0 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
4.8 | 19.3 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
4.2 | 12.6 | GO:0030221 | basophil differentiation(GO:0030221) |
4.1 | 8.2 | GO:0097017 | renal protein absorption(GO:0097017) |
4.0 | 12.0 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
3.6 | 10.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
3.3 | 13.0 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
3.2 | 16.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
3.2 | 9.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
3.1 | 9.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
3.1 | 21.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.0 | 23.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.9 | 2.9 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
2.7 | 10.9 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
2.7 | 16.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.6 | 7.9 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.6 | 7.8 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
2.6 | 7.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
2.6 | 5.1 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
2.6 | 2.6 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
2.5 | 2.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
2.5 | 9.8 | GO:0036233 | glycine import(GO:0036233) |
2.4 | 9.7 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
2.4 | 12.1 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
2.4 | 24.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
2.4 | 2.4 | GO:0001966 | thigmotaxis(GO:0001966) |
2.4 | 14.1 | GO:0030421 | defecation(GO:0030421) |
2.3 | 11.4 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
2.3 | 20.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.3 | 6.8 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
2.2 | 6.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.2 | 2.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.2 | 6.5 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
2.1 | 12.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.1 | 8.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
2.1 | 6.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
2.0 | 16.3 | GO:0031179 | peptide modification(GO:0031179) |
2.0 | 22.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.0 | 4.1 | GO:0014737 | positive regulation of muscle atrophy(GO:0014737) |
2.0 | 6.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.0 | 7.9 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
2.0 | 7.8 | GO:0090096 | lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
2.0 | 2.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
1.9 | 5.8 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
1.9 | 15.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.8 | 7.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
1.8 | 12.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.8 | 3.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.8 | 7.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.8 | 32.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.7 | 7.0 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
1.7 | 5.2 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
1.7 | 50.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.7 | 24.1 | GO:0015816 | glycine transport(GO:0015816) |
1.7 | 5.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.7 | 6.8 | GO:1990091 | sodium-dependent self proteolysis(GO:1990091) |
1.7 | 6.7 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.7 | 19.9 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.6 | 6.6 | GO:0010286 | heat acclimation(GO:0010286) |
1.6 | 4.9 | GO:0035702 | monocyte homeostasis(GO:0035702) |
1.6 | 4.9 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
1.6 | 29.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.6 | 1.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.6 | 12.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.6 | 4.8 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
1.6 | 4.8 | GO:0035425 | autocrine signaling(GO:0035425) |
1.6 | 4.7 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
1.5 | 4.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.5 | 4.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.5 | 7.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.5 | 12.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.5 | 6.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.5 | 4.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
1.5 | 12.1 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.5 | 7.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.5 | 3.0 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
1.5 | 5.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.5 | 8.7 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
1.4 | 5.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.4 | 4.3 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
1.4 | 7.1 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.4 | 4.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.4 | 8.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
1.4 | 5.5 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.4 | 4.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.4 | 6.9 | GO:0002352 | B cell negative selection(GO:0002352) |
1.4 | 5.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.4 | 1.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.4 | 5.4 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
1.4 | 14.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.3 | 9.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.3 | 33.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.3 | 24.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.3 | 9.3 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.3 | 1.3 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
1.3 | 3.9 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
1.3 | 5.2 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.3 | 5.2 | GO:1902896 | terminal web assembly(GO:1902896) |
1.3 | 3.9 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.3 | 10.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.3 | 5.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.3 | 3.9 | GO:0010652 | atrial ventricular junction remodeling(GO:0003294) regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
1.3 | 2.6 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
1.3 | 6.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
1.3 | 2.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.3 | 1.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.3 | 10.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.3 | 7.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.3 | 3.8 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
1.3 | 3.8 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.3 | 5.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.3 | 6.3 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
1.3 | 1.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
1.3 | 2.5 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
1.3 | 3.8 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.3 | 6.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.2 | 5.0 | GO:0015793 | glycerol transport(GO:0015793) |
1.2 | 9.9 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
1.2 | 6.2 | GO:0007494 | midgut development(GO:0007494) |
1.2 | 6.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.2 | 1.2 | GO:0035844 | cloaca development(GO:0035844) |
1.2 | 4.9 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
1.2 | 3.7 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
1.2 | 9.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.2 | 3.6 | GO:1901355 | response to rapamycin(GO:1901355) |
1.2 | 3.6 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.2 | 6.0 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
1.2 | 1.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
1.2 | 5.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.2 | 9.5 | GO:0007144 | female meiosis I(GO:0007144) |
1.2 | 2.3 | GO:0033483 | gas homeostasis(GO:0033483) nitric oxide homeostasis(GO:0033484) |
1.2 | 4.6 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
1.2 | 4.6 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
1.1 | 8.0 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
1.1 | 9.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.1 | 7.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.1 | 3.4 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.1 | 4.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.1 | 1.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
1.1 | 5.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.1 | 6.7 | GO:0015871 | choline transport(GO:0015871) |
1.1 | 6.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 23.1 | GO:0042119 | neutrophil activation(GO:0042119) |
1.1 | 2.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
1.1 | 3.3 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
1.1 | 5.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
1.1 | 6.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
1.1 | 3.2 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.1 | 6.5 | GO:0006116 | NADH oxidation(GO:0006116) |
1.1 | 3.2 | GO:0045004 | DNA replication proofreading(GO:0045004) |
1.1 | 11.8 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
1.1 | 3.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.1 | 22.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.1 | 3.2 | GO:0051714 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
1.1 | 3.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
1.0 | 7.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.0 | 3.1 | GO:0071846 | actin filament debranching(GO:0071846) |
1.0 | 18.7 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
1.0 | 3.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
1.0 | 3.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.0 | 3.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
1.0 | 3.1 | GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
1.0 | 5.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.0 | 3.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.0 | 2.0 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
1.0 | 9.1 | GO:0006113 | fermentation(GO:0006113) |
1.0 | 26.2 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.0 | 8.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.0 | 4.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.0 | 29.9 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
1.0 | 5.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 5.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.0 | 1.0 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.0 | 3.0 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
1.0 | 7.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.0 | 1.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.0 | 8.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.0 | 14.7 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
1.0 | 2.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.0 | 1.0 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
1.0 | 1.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.0 | 1.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.0 | 1.9 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
1.0 | 4.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.0 | 2.9 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
1.0 | 1.9 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 11.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.9 | 6.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.9 | 3.8 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.9 | 3.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.9 | 0.9 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.9 | 6.6 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.9 | 2.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) mediator complex assembly(GO:0036034) DNA replication preinitiation complex assembly(GO:0071163) response to sorbitol(GO:0072708) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.9 | 4.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.9 | 13.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 2.8 | GO:0097045 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) |
0.9 | 2.8 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.9 | 3.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.9 | 4.6 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.9 | 1.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.9 | 2.8 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.9 | 2.7 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.9 | 2.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.9 | 9.1 | GO:0032264 | IMP salvage(GO:0032264) |
0.9 | 1.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.9 | 3.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.9 | 3.6 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.9 | 9.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.9 | 3.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.9 | 6.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.9 | 2.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.9 | 3.6 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.9 | 8.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.9 | 3.5 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.9 | 56.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.9 | 4.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.9 | 21.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.8 | 5.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 3.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.8 | 5.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.8 | 5.0 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.8 | 5.9 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.8 | 9.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.8 | 2.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.8 | 3.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.8 | 5.0 | GO:0044838 | cell quiescence(GO:0044838) |
0.8 | 1.6 | GO:0035934 | corticosterone secretion(GO:0035934) |
0.8 | 2.5 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.8 | 13.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.8 | 1.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.8 | 2.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.8 | 0.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.8 | 4.0 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.8 | 8.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.8 | 6.4 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.8 | 0.8 | GO:2000422 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
0.8 | 9.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 2.4 | GO:0060912 | central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
0.8 | 11.9 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.8 | 7.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.8 | 0.8 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.8 | 3.9 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.8 | 1.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.8 | 3.1 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.8 | 9.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 2.3 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.8 | 3.1 | GO:0015867 | ATP transport(GO:0015867) |
0.8 | 1.6 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.8 | 6.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.8 | 3.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.8 | 7.7 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.8 | 13.1 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.8 | 8.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.8 | 4.6 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.8 | 6.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.8 | 3.1 | GO:0003017 | lymph circulation(GO:0003017) |
0.8 | 7.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.8 | 3.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.8 | 3.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.8 | 6.0 | GO:0015675 | nickel cation transport(GO:0015675) |
0.8 | 3.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.8 | 3.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.8 | 0.8 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.7 | 6.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.7 | 3.7 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.7 | 7.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.7 | 3.7 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.7 | 3.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.7 | 2.9 | GO:0017126 | nucleologenesis(GO:0017126) |
0.7 | 0.7 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.7 | 2.2 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.7 | 2.9 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.7 | 4.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.7 | 1.5 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.7 | 10.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.7 | 5.8 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.7 | 5.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.7 | 4.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 2.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.7 | 2.1 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.7 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.7 | 3.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.7 | 2.1 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.7 | 3.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 4.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 3.5 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
0.7 | 7.6 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.7 | 3.4 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.7 | 4.1 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.7 | 2.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.7 | 4.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.7 | 9.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.7 | 4.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.7 | 2.0 | GO:0051325 | interphase(GO:0051325) mitotic interphase(GO:0051329) |
0.7 | 1.4 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.7 | 2.7 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.7 | 2.0 | GO:0060032 | notochord regression(GO:0060032) |
0.7 | 1.3 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.7 | 3.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.7 | 2.0 | GO:0051455 | attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation(GO:0051455) microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.7 | 6.0 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.7 | 7.3 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 5.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.7 | 2.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.7 | 4.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.7 | 3.9 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.6 | 2.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.6 | 0.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 6.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.6 | 5.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.6 | 2.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 5.1 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.6 | 3.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.6 | 3.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.6 | 0.6 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 4.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 2.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
0.6 | 8.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.6 | 1.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.6 | 1.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.6 | 2.5 | GO:0015904 | tetracycline transport(GO:0015904) |
0.6 | 1.2 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.6 | 1.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 6.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.6 | 1.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.6 | 4.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.6 | 4.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.6 | 2.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.6 | 1.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.6 | 13.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 0.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.6 | 2.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 3.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.6 | 2.4 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.6 | 2.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.6 | 9.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 1.7 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.6 | 0.6 | GO:0051124 | regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) |
0.6 | 2.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 1.7 | GO:0033189 | response to vitamin A(GO:0033189) |
0.6 | 2.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 1.7 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.6 | 5.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 2.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.6 | 1.7 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.6 | 3.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 24.0 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.6 | 1.7 | GO:0090034 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.6 | 5.0 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.6 | 6.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 2.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 14.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 13.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.5 | 8.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 6.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 1.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.5 | 3.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.5 | 12.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 7.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 1.6 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.5 | 3.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.5 | 1.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 3.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 3.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 11.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.5 | 2.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.6 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.5 | 6.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 1.1 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.5 | 1.6 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.5 | 2.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 4.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 11.0 | GO:0031100 | organ regeneration(GO:0031100) |
0.5 | 2.1 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.5 | 4.7 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.5 | 5.7 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.5 | 8.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 1.0 | GO:0019046 | release from viral latency(GO:0019046) |
0.5 | 1.5 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.5 | 2.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 1.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.5 | 2.6 | GO:0051534 | regulation of NFAT protein import into nucleus(GO:0051532) negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 2.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.5 | 1.0 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.5 | 2.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 12.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.5 | 4.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.5 | 0.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 6.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 2.0 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.5 | 15.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.5 | 1.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 2.0 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.5 | 8.8 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.5 | 1.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.5 | 7.8 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.5 | 1.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.5 | 5.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.5 | 0.5 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.5 | 3.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 1.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 14.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.5 | 2.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.5 | 2.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 0.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 4.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 0.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.5 | 1.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.5 | 2.3 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.5 | 1.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 5.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.5 | 4.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 4.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 2.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.5 | 0.9 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.5 | 6.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.5 | 2.3 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 0.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.5 | 2.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 5.8 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.4 | 7.6 | GO:0043486 | histone exchange(GO:0043486) |
0.4 | 8.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.4 | 1.8 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.4 | 0.9 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) regulation of chromatin silencing at telomere(GO:0031938) |
0.4 | 0.4 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.4 | 1.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 1.8 | GO:0070649 | establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.8 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.4 | 2.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 3.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.4 | 0.4 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.4 | 2.6 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.4 | 2.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.4 | 1.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 2.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 6.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 1.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 1.7 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.4 | 0.4 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.4 | 3.0 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 3.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 1.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 3.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 4.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 2.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.4 | 2.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 1.3 | GO:0072014 | proximal tubule development(GO:0072014) |
0.4 | 0.4 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.4 | 8.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.4 | 0.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.4 | 2.9 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.4 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 1.2 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.4 | 1.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.4 | 1.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 1.2 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 3.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 1.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.4 | 0.4 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
0.4 | 5.6 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.4 | 10.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 1.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 3.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 1.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.4 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 2.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.4 | 0.8 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) |
0.4 | 1.2 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.4 | 4.4 | GO:0033280 | response to vitamin D(GO:0033280) |
0.4 | 0.8 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.4 | 5.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 3.1 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 3.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.4 | 1.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.4 | 1.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 7.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.4 | 3.1 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.4 | 1.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 2.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.4 | 1.2 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 5.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 0.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 9.6 | GO:0030220 | platelet formation(GO:0030220) |
0.4 | 1.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 1.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.4 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 6.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 1.1 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.4 | 6.5 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.4 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 3.8 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 0.8 | GO:0019042 | viral latency(GO:0019042) establishment of viral latency(GO:0019043) |
0.4 | 0.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.4 | 12.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.4 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 6.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 3.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.4 | 7.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 3.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 2.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.4 | 1.8 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 4.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 2.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.4 | 1.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 3.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.4 | 1.5 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.4 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 7.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.4 | 3.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 1.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 0.7 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 5.6 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.4 | 11.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 1.4 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.3 | 3.1 | GO:0015074 | DNA integration(GO:0015074) |
0.3 | 1.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.4 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.3 | 1.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 2.1 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.3 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.3 | 2.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 1.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 2.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 1.7 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.3 | 1.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 1.0 | GO:0045472 | response to ether(GO:0045472) |
0.3 | 1.0 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.3 | 2.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.3 | 1.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.3 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 1.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 1.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 2.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 4.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 1.0 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.3 | 2.3 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.3 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 1.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 1.3 | GO:0009816 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.3 | 0.6 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.3 | 1.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.3 | 1.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 5.8 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 2.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 1.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 9.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 1.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 1.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 3.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 1.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 0.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 3.1 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.3 | 11.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 1.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 3.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 1.9 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 4.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 1.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 0.9 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.3 | 3.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 3.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.3 | 0.9 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.3 | 0.6 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.3 | 1.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.3 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.3 | 2.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 6.0 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 0.3 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.3 | 1.2 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.3 | 4.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.3 | 1.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.3 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 7.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 2.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 1.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.3 | 0.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 1.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.9 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.3 | 2.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 6.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 5.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.3 | 0.3 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.3 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 4.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 2.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 2.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 3.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 1.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.6 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.3 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 1.9 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
0.3 | 13.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 0.8 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 2.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.3 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 5.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.3 | 3.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.5 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.3 | 0.5 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.3 | 3.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 0.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.6 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.3 | 5.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 15.2 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.3 | 1.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.3 | 1.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.3 | 0.5 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.3 | 2.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.3 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 2.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 6.9 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.3 | 3.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 1.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.3 | 1.3 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 4.7 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 8.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 0.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.3 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 3.8 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.3 | 2.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 1.0 | GO:0046083 | adenine salvage(GO:0006168) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.3 | 0.5 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
0.3 | 1.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 1.3 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.3 | 6.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.8 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.3 | 18.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 4.7 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 1.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 1.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 2.7 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.2 | 1.7 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 2.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.5 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.2 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 3.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 4.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 2.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 7.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 1.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.4 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.2 | 1.2 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.2 | 0.5 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.9 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.9 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.2 | 3.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 4.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 8.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.7 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
0.2 | 1.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 10.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.2 | 0.4 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.2 | 0.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 4.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 1.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 1.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 2.7 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 4.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 0.6 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.2 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.2 | 0.2 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 6.0 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.2 | 0.4 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.2 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 1.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 2.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 0.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 1.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.4 | GO:0046831 | regulation of mRNA export from nucleus(GO:0010793) regulation of RNA export from nucleus(GO:0046831) |
0.2 | 1.4 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.2 | 1.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 2.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 0.2 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 1.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.2 | 1.0 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 1.0 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 2.0 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 2.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.6 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.2 | 1.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 1.0 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 2.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 6.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.6 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.2 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.8 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.2 | 0.8 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 0.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 6.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 2.1 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.2 | 0.2 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) positive regulation of T cell tolerance induction(GO:0002666) |
0.2 | 0.2 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) |
0.2 | 27.7 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.2 | 2.5 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 2.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.8 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
0.2 | 0.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.6 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.2 | 0.9 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 2.0 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.2 | 0.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.2 | 2.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.2 | GO:0002590 | negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.2 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 2.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 5.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.4 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.8 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.2 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 11.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.2 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.5 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.2 | 0.9 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.2 | 1.4 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
0.2 | 2.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.9 | GO:1990743 | protein sialylation(GO:1990743) |
0.2 | 2.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.5 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.2 | 3.4 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.2 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.8 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 0.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 1.3 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.2 | 2.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 1.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 4.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 3.6 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.2 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.0 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 1.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 2.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 1.4 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 2.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 0.2 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 2.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 2.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 2.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 7.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.4 | GO:0046144 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.1 | 1.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.4 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 1.3 | GO:0060974 | cell migration involved in heart formation(GO:0060974) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 4.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 1.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 1.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.3 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.1 | 4.2 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.4 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.1 | 1.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 1.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.4 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.1 | 1.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.3 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.8 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 4.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.7 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.5 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.1 | 0.4 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 1.4 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 1.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 2.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 1.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 4.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 2.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.1 | 3.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 4.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 0.6 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.1 | 0.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 1.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 2.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.8 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
0.1 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 2.5 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 1.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 5.2 | GO:0016573 | histone acetylation(GO:0016573) |
0.1 | 0.7 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.1 | 1.0 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 2.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 3.9 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 2.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.9 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.1 | 7.5 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.1 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 6.2 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 2.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 5.0 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.8 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 4.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 1.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 5.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.7 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.1 | 6.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.1 | 0.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.6 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 1.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 1.7 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 0.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 8.7 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.1 | 0.3 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.1 | 1.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 4.7 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.1 | 0.3 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.1 | 2.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.1 | 1.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.1 | 0.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.3 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.8 | GO:0034103 | regulation of tissue remodeling(GO:0034103) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 1.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.1 | 0.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 1.0 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 0.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 0.1 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.1 | 0.9 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 | 0.3 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.4 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.4 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.1 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.2 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.1 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.1 | 0.1 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.1 | 1.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.1 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 2.6 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) |
0.1 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.4 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 0.7 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.1 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 1.3 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.5 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.0 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.0 | 0.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.0 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 2.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.0 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 3.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.1 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.0 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.2 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.0 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 4.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 1.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.2 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.0 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.0 | GO:1903487 | regulation of lactation(GO:1903487) |
0.0 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.2 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.0 | 0.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.3 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 1.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.0 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.0 | 0.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.0 | 0.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.0 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.0 | 0.1 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 1.9 | GO:0031589 | cell-substrate adhesion(GO:0031589) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.4 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.0 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.0 | 0.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.4 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
6.8 | 20.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
5.8 | 17.4 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
4.5 | 31.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
4.5 | 22.4 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
3.7 | 40.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.5 | 13.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
3.0 | 12.0 | GO:0001740 | Barr body(GO:0001740) |
2.8 | 11.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
2.5 | 12.3 | GO:0071953 | elastic fiber(GO:0071953) |
2.3 | 9.4 | GO:0043511 | inhibin complex(GO:0043511) |
2.3 | 18.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.3 | 9.2 | GO:0014802 | terminal cisterna(GO:0014802) |
2.3 | 6.9 | GO:0031904 | endosome lumen(GO:0031904) |
2.2 | 9.0 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
2.1 | 17.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
2.1 | 8.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.0 | 10.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.0 | 6.1 | GO:1990031 | pinceau fiber(GO:1990031) |
1.9 | 11.5 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
1.9 | 5.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.8 | 5.3 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.8 | 5.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
1.8 | 5.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.7 | 12.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.7 | 26.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.7 | 5.2 | GO:1990879 | CST complex(GO:1990879) |
1.7 | 6.8 | GO:0036284 | tubulobulbar complex(GO:0036284) |
1.7 | 11.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.7 | 9.9 | GO:0031523 | Myb complex(GO:0031523) |
1.6 | 24.4 | GO:0042581 | specific granule(GO:0042581) |
1.6 | 4.9 | GO:1902560 | GMP reductase complex(GO:1902560) |
1.6 | 24.1 | GO:0044327 | dendritic spine head(GO:0044327) |
1.6 | 4.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.5 | 26.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.5 | 9.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.5 | 6.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.4 | 11.3 | GO:0008091 | spectrin(GO:0008091) |
1.4 | 5.6 | GO:0034683 | integrin alphav-beta3 complex(GO:0034683) |
1.4 | 9.9 | GO:0005638 | lamin filament(GO:0005638) |
1.4 | 2.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.4 | 23.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.3 | 4.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
1.3 | 14.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.3 | 10.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.2 | 20.9 | GO:0090543 | Flemming body(GO:0090543) |
1.2 | 7.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.2 | 11.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.2 | 15.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.2 | 2.4 | GO:0097470 | ribbon synapse(GO:0097470) |
1.2 | 6.0 | GO:0000799 | nuclear condensin complex(GO:0000799) |
1.2 | 2.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
1.2 | 11.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.2 | 5.8 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
1.1 | 5.7 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
1.1 | 30.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
1.1 | 4.5 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
1.1 | 6.7 | GO:0097255 | R2TP complex(GO:0097255) |
1.1 | 2.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.1 | 16.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.1 | 20.3 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 7.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.0 | 2.1 | GO:0005685 | U1 snRNP(GO:0005685) |
1.0 | 9.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.0 | 9.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 1.0 | GO:1902737 | dendritic filopodium(GO:1902737) |
1.0 | 2.9 | GO:0048179 | activin receptor complex(GO:0048179) |
1.0 | 5.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.9 | 2.8 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.9 | 1.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 2.8 | GO:0034455 | t-UTP complex(GO:0034455) |
0.9 | 0.9 | GO:0035101 | FACT complex(GO:0035101) |
0.9 | 5.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.8 | 5.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.8 | 9.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 27.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 7.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.8 | 6.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 9.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.8 | 10.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.8 | 7.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.7 | 12.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.7 | 8.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 1.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.7 | 3.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 4.1 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.7 | 11.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.7 | 4.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.7 | 28.6 | GO:0002102 | podosome(GO:0002102) |
0.7 | 10.5 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 16.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.6 | 3.8 | GO:0001652 | granular component(GO:0001652) |
0.6 | 3.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.6 | 1.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.6 | 3.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.6 | 5.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 36.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 4.3 | GO:0000796 | condensin complex(GO:0000796) |
0.6 | 2.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 0.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.6 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.6 | 1.8 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 12.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.6 | 5.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 7.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.6 | 1.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.6 | 5.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.6 | 4.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 5.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.6 | 7.3 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 2.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.6 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 3.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 3.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 27.5 | GO:0015030 | Cajal body(GO:0015030) |
0.5 | 2.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 2.2 | GO:0008623 | CHRAC(GO:0008623) |
0.5 | 10.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.5 | 1.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 2.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 6.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.5 | 1.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 5.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 1.9 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 1.4 | GO:0032545 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.5 | 2.9 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.5 | 3.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.5 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 2.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 2.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.5 | 24.5 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 3.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 1.8 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.4 | 2.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.4 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 7.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 18.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 1.3 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.4 | 2.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 4.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 1.3 | GO:0070992 | translation initiation complex(GO:0070992) |
0.4 | 7.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 44.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 2.1 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.4 | 6.0 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 8.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 1.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 10.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 25.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 7.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 13.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 2.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 0.4 | GO:0019034 | viral replication complex(GO:0019034) |
0.4 | 5.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 3.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 4.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 3.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 25.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 3.3 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 14.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 1.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 2.9 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.4 | 21.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 6.4 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 2.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 8.1 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.3 | 7.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 6.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 4.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 2.4 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 1.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 5.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 2.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 6.8 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 4.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 7.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 13.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 1.0 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.3 | 1.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 3.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 1.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 39.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 1.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 4.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 5.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 3.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 28.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 5.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 5.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 3.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 2.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 7.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.9 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.3 | 12.8 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 2.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 6.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.3 | 12.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 20.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 2.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 2.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 7.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.0 | GO:0071920 | cleavage body(GO:0071920) |
0.3 | 5.9 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 3.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 0.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 7.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 4.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 1.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 19.5 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 3.0 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.2 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.2 | 0.5 | GO:0031673 | H zone(GO:0031673) |
0.2 | 2.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 21.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 2.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 1.1 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.2 | 0.8 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 4.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.6 | GO:0034066 | RIC1-RGP1 guanyl-nucleotide exchange factor complex(GO:0034066) |
0.2 | 2.1 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.2 | 15.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 3.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 2.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 2.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 24.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 3.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 1.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 4.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 1.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 16.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 2.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 1.0 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 2.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 17.1 | GO:0016605 | PML body(GO:0016605) |
0.2 | 7.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 10.1 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 1.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.3 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
0.2 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 3.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 3.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 8.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 2.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 4.3 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 6.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.4 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.1 | 1.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 23.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 14.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 7.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 14.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 26.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 13.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 2.2 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 1.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 1.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 12.1 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 13.2 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.8 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 23.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 7.7 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 20.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 6.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.7 | GO:0071914 | prominosome(GO:0071914) |
0.1 | 0.3 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 1.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.8 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 4.9 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 0.1 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.1 | 1.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 2.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.3 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.1 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 29.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 16.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.9 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.8 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 6.8 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 1.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 0.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 1.0 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.0 | GO:0034657 | GID complex(GO:0034657) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 30.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.2 | 12.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
3.8 | 33.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.6 | 3.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
3.4 | 20.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
3.4 | 17.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
3.4 | 10.1 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
3.3 | 10.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
3.2 | 12.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
3.2 | 16.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
2.8 | 8.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
2.7 | 10.8 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.7 | 5.4 | GO:0048030 | disaccharide binding(GO:0048030) |
2.5 | 7.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
2.4 | 34.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
2.1 | 10.6 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
2.1 | 6.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.1 | 27.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.0 | 17.7 | GO:0034711 | inhibin binding(GO:0034711) |
1.9 | 11.7 | GO:1990254 | keratin filament binding(GO:1990254) |
1.9 | 5.8 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
1.9 | 30.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.9 | 22.7 | GO:0008061 | chitin binding(GO:0008061) |
1.9 | 5.7 | GO:0047291 | lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
1.9 | 18.6 | GO:0004064 | arylesterase activity(GO:0004064) |
1.8 | 11.1 | GO:0048495 | Roundabout binding(GO:0048495) |
1.8 | 5.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.8 | 10.9 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
1.8 | 9.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
1.8 | 7.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
1.8 | 15.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.8 | 12.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
1.7 | 10.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.7 | 10.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.7 | 6.7 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
1.6 | 16.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.6 | 34.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.6 | 6.5 | GO:0045159 | myosin II binding(GO:0045159) |
1.6 | 4.9 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.6 | 73.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.6 | 1.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.6 | 1.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.6 | 4.8 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.6 | 4.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.6 | 9.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.6 | 9.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.6 | 4.7 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
1.5 | 4.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.5 | 12.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.5 | 5.9 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.5 | 4.4 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.5 | 5.8 | GO:0043532 | angiostatin binding(GO:0043532) |
1.5 | 11.6 | GO:0051425 | PTB domain binding(GO:0051425) |
1.4 | 7.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.4 | 4.2 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
1.4 | 2.8 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.4 | 12.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.4 | 4.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.4 | 5.4 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.3 | 5.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.3 | 5.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.3 | 6.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
1.3 | 9.2 | GO:0031013 | troponin I binding(GO:0031013) |
1.3 | 3.9 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
1.3 | 3.9 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.3 | 6.5 | GO:1990188 | euchromatin binding(GO:1990188) |
1.3 | 11.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.3 | 7.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
1.3 | 5.0 | GO:0072354 | histone kinase activity (H3-T3 specific)(GO:0072354) |
1.2 | 22.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.2 | 3.7 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
1.2 | 3.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
1.2 | 6.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.2 | 3.6 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.2 | 7.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.2 | 8.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.2 | 10.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 17.3 | GO:0030274 | LIM domain binding(GO:0030274) |
1.1 | 3.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.1 | 16.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.1 | 5.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
1.1 | 9.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.1 | 3.4 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.1 | 11.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 4.5 | GO:0030519 | snoRNP binding(GO:0030519) |
1.1 | 3.3 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
1.1 | 10.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.1 | 10.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
1.0 | 16.7 | GO:0051861 | glycolipid binding(GO:0051861) |
1.0 | 3.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 12.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.0 | 73.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.0 | 8.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
1.0 | 6.9 | GO:0015265 | urea channel activity(GO:0015265) |
1.0 | 3.0 | GO:0019978 | interleukin-3 receptor activity(GO:0004912) interleukin-3 binding(GO:0019978) |
1.0 | 2.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.0 | 11.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.9 | 24.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.9 | 4.7 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.9 | 3.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 5.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 3.7 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.9 | 0.9 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
0.9 | 5.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 8.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.9 | 9.9 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.9 | 3.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.9 | 5.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.9 | 2.6 | GO:0070122 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.9 | 7.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.9 | 4.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.9 | 12.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.9 | 5.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.8 | 1.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.8 | 5.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 1.7 | GO:0048185 | activin binding(GO:0048185) |
0.8 | 2.5 | GO:0032093 | SAM domain binding(GO:0032093) |
0.8 | 7.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 7.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.8 | 20.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.8 | 19.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.8 | 2.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.8 | 5.7 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 4.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.8 | 10.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.8 | 5.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.8 | 1.6 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.8 | 2.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 2.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.8 | 18.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.8 | 13.4 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 2.3 | GO:0036004 | GAF domain binding(GO:0036004) |
0.8 | 2.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.8 | 17.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.8 | 3.1 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.8 | 24.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.8 | 2.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.8 | 6.0 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.7 | 6.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.7 | 6.7 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.7 | 2.2 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.7 | 5.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.7 | 8.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.7 | 2.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 2.9 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.7 | 2.9 | GO:0005113 | patched binding(GO:0005113) |
0.7 | 2.9 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.7 | 2.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.7 | 0.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 2.8 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.7 | 4.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.7 | 3.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 2.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 4.1 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.7 | 11.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 8.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.7 | 2.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.7 | 1.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.7 | 4.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.7 | 6.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.7 | 4.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.7 | 4.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 1.3 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.6 | 2.6 | GO:0004335 | galactokinase activity(GO:0004335) |
0.6 | 3.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 1.9 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.6 | 1.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.6 | 3.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.6 | 1.9 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.6 | 1.9 | GO:0016872 | inositol-3-phosphate synthase activity(GO:0004512) intramolecular lyase activity(GO:0016872) |
0.6 | 2.5 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.6 | 3.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.6 | 4.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.6 | 5.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 9.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 4.8 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.6 | 6.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.6 | 1.8 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.6 | 3.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 4.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 34.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 4.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.6 | 6.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 4.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 2.3 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.6 | 3.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 5.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 1.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.6 | 2.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.5 | 3.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 2.2 | GO:0008311 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.5 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.5 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.5 | 10.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 8.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 2.1 | GO:0070976 | TIR domain binding(GO:0070976) |
0.5 | 42.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 8.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 5.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 6.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.5 | 1.6 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
0.5 | 2.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.5 | 20.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 12.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.5 | 7.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 15.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.5 | 1.0 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.5 | 3.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 2.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.5 | 5.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 2.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.5 | 2.0 | GO:0051435 | BH4 domain binding(GO:0051435) |
0.5 | 5.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 13.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 2.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.5 | 1.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 13.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 8.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 1.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.5 | 2.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.5 | 1.4 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.5 | 5.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 9.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 13.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 3.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 2.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 1.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.5 | 1.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 5.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 17.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 5.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 1.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.5 | 2.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 49.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.5 | 1.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 1.4 | GO:0018169 | ribosomal S6-glutamic acid ligase activity(GO:0018169) |
0.5 | 1.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 1.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.5 | 2.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.5 | 1.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.4 | 1.8 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.4 | 1.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 1.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 3.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.4 | 0.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 4.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 1.8 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.4 | 5.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 14.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 0.9 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.4 | 2.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 5.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 10.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 3.0 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.4 | 35.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 13.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 4.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 1.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 0.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.4 | 2.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.4 | 2.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 2.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 3.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 17.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 5.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 2.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 1.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 14.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 1.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.4 | 2.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 2.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 3.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.4 | 7.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 12.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.4 | 4.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 13.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 3.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 5.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 1.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 1.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 1.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 2.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 1.5 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.4 | 1.1 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.4 | 3.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 3.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 2.5 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 1.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.4 | 3.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.4 | 0.7 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 1.4 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.4 | 3.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 2.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 1.1 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
0.4 | 1.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 2.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 1.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 1.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.4 | 1.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 2.1 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.3 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 2.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 2.0 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 1.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 3.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 3.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 8.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 3.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 6.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 2.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 1.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 2.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 6.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 0.9 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.3 | 2.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 23.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 0.6 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.3 | 2.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.6 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.3 | 1.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 0.9 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.3 | 3.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 2.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.3 | 1.8 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.3 | 0.9 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
0.3 | 4.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 20.7 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 0.9 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.9 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.3 | 2.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 4.0 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 3.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 0.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 3.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 2.2 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 1.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 0.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.3 | 2.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 1.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 1.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.3 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 1.9 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.3 | 1.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 1.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 4.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.8 | GO:0070401 | NADP+ binding(GO:0070401) |
0.3 | 1.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.3 | 0.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 1.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 0.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.3 | 5.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 3.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 1.0 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
0.3 | 0.8 | GO:0008456 | alpha-N-acetylgalactosaminidase activity(GO:0008456) |
0.2 | 8.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.7 | GO:0003999 | adenine binding(GO:0002055) adenine phosphoribosyltransferase activity(GO:0003999) |
0.2 | 4.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 5.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 2.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 4.5 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 43.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 0.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 0.9 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.2 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 6.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 2.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 5.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.7 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 14.0 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 1.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 0.7 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 1.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 4.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 2.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 9.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 2.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 2.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.6 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.2 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 6.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 3.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 4.1 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 10.4 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 1.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.2 | 4.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.8 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.2 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.6 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.2 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 1.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 1.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.2 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.9 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
0.2 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 9.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.2 | 1.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 5.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 6.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 5.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 2.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 2.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 1.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 2.1 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 2.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 5.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.2 | 3.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 12.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 4.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 8.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.1 | 6.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 14.7 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 1.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 1.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 0.4 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 18.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 3.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 4.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 1.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 2.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.8 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 2.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 2.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.6 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.1 | 0.4 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.1 | 1.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 1.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 2.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 1.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.4 | GO:0004134 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.1 | 7.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.1 | 2.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.0 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.4 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.1 | 2.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 8.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 24.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 14.6 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 1.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 3.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 6.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0097617 | annealing activity(GO:0097617) |
0.1 | 16.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 4.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.7 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.3 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.1 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 3.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 13.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.3 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.1 | 2.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 4.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 2.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 3.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 8.5 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 2.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.4 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 2.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 2.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 20.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 2.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.1 | 14.5 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 3.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 7.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 11.8 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 1.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.0 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 1.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 4.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 1.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 1.0 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 35.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 0.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.7 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 3.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.7 | 16.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.4 | 90.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.3 | 49.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.0 | 16.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.0 | 54.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.0 | 15.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 53.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.8 | 12.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.8 | 36.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 17.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 32.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 45.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 15.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.7 | 55.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.7 | 24.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.7 | 33.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 7.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 15.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 38.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.6 | 4.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.6 | 62.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 9.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 21.0 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 8.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 20.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 3.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.6 | 51.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 13.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 5.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.5 | 4.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 5.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 1.0 | ST ADRENERGIC | Adrenergic Pathway |
0.5 | 5.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 29.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 14.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 4.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 18.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 4.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 17.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 13.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.5 | 0.9 | ST GAQ PATHWAY | G alpha q Pathway |
0.4 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 7.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 6.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 3.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 16.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 1.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.4 | 16.5 | PID ATR PATHWAY | ATR signaling pathway |
0.4 | 15.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 8.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 2.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 14.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 10.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.4 | 2.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 9.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 18.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 8.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 7.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 4.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 6.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 10.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.3 | 2.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 1.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 27.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 4.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 5.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 6.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 5.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 23.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 15.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 48.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 1.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 11.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 7.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 5.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 4.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 3.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 9.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 33.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 1.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 1.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 10.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 3.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 6.3 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 8.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 5.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 11.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 64.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.9 | 13.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.7 | 26.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.3 | 6.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.3 | 37.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.1 | 5.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.1 | 21.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.1 | 22.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
1.0 | 17.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.0 | 13.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.0 | 56.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.0 | 20.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.0 | 2.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.9 | 0.9 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.9 | 18.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.9 | 1.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.9 | 10.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.9 | 3.6 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.9 | 9.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.9 | 7.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.8 | 18.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 10.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 52.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 9.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 9.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.8 | 8.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 34.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 16.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.7 | 25.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.7 | 19.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 9.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.7 | 17.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 20.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.7 | 17.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.7 | 8.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.7 | 10.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 61.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.7 | 14.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 6.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 12.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 21.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.6 | 2.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.6 | 15.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.6 | 19.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 15.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 3.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 12.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 15.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 2.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 2.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.5 | 4.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 33.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 29.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 10.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.5 | 2.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.5 | 20.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 0.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.5 | 19.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.5 | 3.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 11.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 3.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 34.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.4 | 1.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.4 | 6.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 4.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 36.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 3.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 14.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 10.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.4 | 6.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 30.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 1.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 50.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 3.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.4 | 15.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 15.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 8.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 9.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 6.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 3.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 2.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 23.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 15.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 7.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 1.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 3.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 18.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 8.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 12.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 2.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 10.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 10.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 5.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 7.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 3.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 8.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 11.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 6.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 10.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 1.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 4.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.4 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 7.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 4.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 5.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 10.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 17.3 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.2 | 2.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 7.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 3.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 3.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 3.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 4.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 3.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 10.9 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 19.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 3.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 4.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 3.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 13.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 4.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 6.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.9 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 9.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.6 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.1 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.7 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.8 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 2.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.9 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.1 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 10.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |